Inicio>>Signaling Pathways>> Others>>ML367

ML367

Catalog No.GC36630

ML367 es un potente inhibidor de la estabilizaciÓn de la proteÍna 5 (ATAD5) que contiene el dominio AAA de la familia ATPasa, actÚa como una molécula de sonda que tiene una actividad inhibidora micromolar baja. ML367 bloquea las vÍas de reparaciÓn del ADN, suprime las respuestas generales al daÑo del ADN, incluida la fosforilaciÓn de RPA32 y la fosforilaciÓn de CHK1 en respuesta a la radiaciÓn UV.

Products are for research use only. Not for human use. We do not sell to patients.

ML367 Chemical Structure

Cas No.: 381168-77-0

Tamaño Precio Disponibilidad Cantidad
10mM (in 1mL DMSO)
248,00 $
Disponible
5mg
225,00 $
Disponible
10mg
375,00 $
Disponible
50mg
225,00 $
Disponible
100mg
405,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

ML367 is a potent inhibitor of ATPase family AAA domain-containing protein 5 (ATAD5) stabilization, acts as a probe molecule that has low micromolar inhibitory activity. ML367 blocks DNA repair pathways, suppresses general DNA damage responses including RPA32-phosphorylation and CHK1-phosphorylation in response to UV irradiation[1]. ATAD5[1]

ML367 (0-40 μM, 16 hours) inhibits FLAG-ATAD5 stabilization in HEK293T cells in the presence or absence of 20 μM 5-FUrd[1]. Western Blot Analysis[1] Cell Line: HEK293T cells

[1]. Rohde JM, et al. Discovery of ML367, inhibitor of ATAD5 stabilization. Probe Reports from the NIH Molecular Libraries Program.

Reseñas

Review for ML367

Average Rating: 5 ★★★★★ (Based on Reviews and 10 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for ML367

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.